Sinovac Biotech, Ltd. · NASDAQ:SVA

Vivo Capital IX, LLC reported a 6.30% stake in Sinovac Biotech, Ltd. (Schedule 13D/A)

Event Jun 11, 2025 · Filed Jun 13, 2025

Vivo Capital IX, LLC reported a 6.30% stake in Sinovac Biotech, Ltd., 4,541,764 shares, with active intent on Jun 11, 2025. Filed Jun 13, 2025 (Schedule 13D/A).

Stake
6.30%
Shares
4,541,764
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Vivo Capital VIII, LLC1.90%1,361,236
Vivo Capital IX, LLC6.30%4,541,764

Source

View original at SEC

Related